Media

Here in the media centre you will find a range of resources including our latest and archived press releases, statements from our CEO, speeches and presentations, information on our social media policy, and our photo and video library.

From our CEO

A selection of videos and publications featuring our CEO Sir Andrew Witty.

Speeches & presentations

Find the latest and archived speeches and presentations from GSK’s senior executives.

Press releases

These press releases are intended for business journalists and analysts/investors.
24 May 2013

Grant to Help Coordinate Campaign to Train One Million Community Health Workers in sub-Saharan Africa

In an effort to broadly expand the reach of health care services in sub-Saharan Africa, GlaxoSmithKline (GSK) will contribute $750,000 to the One Million Community Health Workers Campaign.

21 May 2013

GlaxoSmithKline awarded up to $200 million by U.S. government to develop new antibiotics

GlaxoSmithKline (GSK) plc and the Biomedical Advanced Research and Development Authority (BARDA), have agreed to a first of its kind collaboration that will support the development of several antibiotics to fight antibiotic resistance and bioterrorism.

10 May 2013

BREO™ ELLIPTA™ gains US approval for the treatment of COPD

GlaxoSmithKline plc (LSE/NYSE: GSK) and Theravance, Inc. (NASDAQ: THRX) today announced that the US Food and Drug Administration (FDA) has approved BREO™ ELLIPTA™ as an inhaled long-term, once-daily maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema.

Social media

More about our social media activities

Annual Report 2012

Download the 2012 Annual Report

Information for investors